Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Papivax LLC
Profile last edited on: 7/24/19      CAGE: 6NDM5      UEI: ETK8BT7KYHV8

Business Identifier: Treatment of human papillomavirus (HPV)
Year Founded
2010
First Award
2013
Latest Award
2015
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

645 Baltimore Annapolis Boulevard Suite 217
Severna Park, MD 21146
   (301) 906-2682
   N/A
   www.papivax.com
Location: Single
Congr. District: 04
County: Anne Arundel

Public Profile

Papivax LLC is developing a vaccine to treat human papillomavirus (HPV), which is a leading cause of cervical cancer. The technology is spun out of research from Johns Hopkins University.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$587,996
Phase II Dollars
$295,392
Total Awarded
$883,388

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2015 2 NIH $595,194
Project Title: Therapeutic/Preventive Vaccination Against Muspv
2013 1 NIH $288,194
Project Title: Therapeutic Vaccination Against Genital HPV Infection

Key People / Management

  Joseph Boystak -- Co-Founder

  Yung Nien Chang -- Co-Founder

  Richard Roden -- Co-Founder

  TC Wu -- Co-Founder

Company News

There are no news available.